Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial
Frontiers in Psychiatry · 23.04.2026 · 17
DOI: 10.3389/fpsyt.2026.1810049 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Psychiatry, online erschienen am 23.04.2026. Verfasst von Cancan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry department, Tianjin Anding Hospital, Tianjin, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite growing interest in mindfulness-based interventions (MBI) for Generalized Anxiety Disorder (GAD), robust evidence for their adjunctive use alongside first-line pharmacotherapy is scarce. This study aimed to evaluate the efficacy of MBI as adjunct to pharmacotherapy in adults with GAD, assessing multidimensional outcomes.
Methods
In this randomized controlled trial, 106 adults diagnosed with DSM-5 GAD and on stable pharmacotherapy were randomly assigned to intervention group or control group (n=53). The intervention group received an 8-week, group-based MBI adapted from Mindfulness-Based Cognitive Therapy in addition to their ongoing pharmacotherapy. The control group received pharmacotherapy plus an active control condition consisting of structured psychoeducation (n=53). The primary outcome was the change in clinician-rated anxiety severity on the Hamilton Anxiety Rating Scale (HAMA). Secondary outcomes included self-reported anxiety (Self-Rating Anxiety Scale, SAS), mindfulness skills (Five Facet Mindfulness Questionnaire, FFMQ), sleep quality (Pittsburgh Sleep Quality Index, PSQI), negative cognitive bias (Negative Cognitive Processing Bias Questionnaire, NCPBQ), and psychosocial functioning (Global Assessment of Functioning-Modified, GAF-M). Linear mixed-effects model was used for analysis.
Results
The intervention group demonstrated a significantly greater reduction in HAMA scores post-intervention compared to the control group (18.6 vs. 22.5; P < 0.05), with a significant group × time interaction (Estimate = -3.68, P < 0.05). Significant between-group improvements favoring the intervention group were also confirmed across all secondary outcomes: SAS (Estimate = -4.29, P < 0.05), FFMQ (Estimate = 20.25, P < 0.05), PSQI (Estimate = -2.36, P < 0.05), NCPBQ (Estimate = -6.75, P < 0.05), and GAF-M (Estimate = 6.98, P < 0.05).
Conclusion
An adjunctive, 8-week MBI significantly reduces anxiety and enhances mindfulness, sleep, cognitive function, and psychosocial well-being in medicated GAD patients. These findings support integrating structured MBI into standard care to optimize functional recovery alongside symptom management.
Trial registration
The study was registered prior to conducting the research in the Chinese Clinical Trial Registry ( https://www.chictr.org.cn ) on September 26, 2024 with the trial identification number ChiCTR2400090284
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Psychiatry department, Tianjin Anding Hospital, Tianjin, China.
Zitieren
APA
Zhang, C., Zhang, J., & Sun, L. (2026). Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1810049
Vancouver
Zhang C, Zhang J, Sun L. Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1810049
BibTeX
@article{Zhang2026,
author = {Zhang, Cancan and Zhang, Jin and Sun, Lei},
title = {Mindfulness-based intervention for patients with generalized anxiety disorder: a randomized controlled trial},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1810049}
}
EUVIMED